株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

微生物同定の世界市場:成長、動向、および予測(2019年~2024年)

Microbial Identification Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 708597
出版日 ページ情報 英文 117 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.10円で換算しております。
微生物同定の世界市場:成長、動向、および予測(2019年~2024年) Microbial Identification Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年11月01日 ページ情報: 英文 117 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

当レポートは世界の微生物同定市場について調査しており、市場機会や動向、成長および阻害要因、製品&サービス・方法・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 成長要因
    • 感染症の発生率の上昇
    • 微生物同定における技術的進歩
    • 食品安全への関心の高まり
    • 微生物同定を促進するための政府の取り組みおよび資金
  • 阻害要因
    • 自動化された微生物同定システムの高いコスト
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメント

  • 製品・サービス別
    • 機器
    • 消耗品
    • サービス
  • 方法別
    • 表現型
    • 遺伝子型
    • プロテオミクス
  • 用途別
    • 診断
    • 食品・飲料
    • 医薬品
    • 化粧品・パーソナルケア製品
    • その他
  • エンドユーザー別
    • 病院、診療所、診断研究所
    • 食品・飲料メーカー
    • 製薬企業
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Becton, Dickinson and Company
    • Biolog, Inc.
    • BioMerieux SA
    • Bruker Corporation
    • Charles River Laboratories International, Inc.
    • Danaher Corporation
    • Eurofins Scientific SE
    • Merck Millipore (Merck KGaA)
    • 株式会社島津製作所
    • Thermo Fisher Scientific Inc.
    • VWR Corporation

第7章 市場機会および今後の動向

目次
Product Code: 64219

Market Overview

Several technological advances using simple molecular methods have become available in recent years for microbial identification and show potential for cost-benefit, specifically, peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) and targeted real-time PCR such as GeneXpert assays. PNA-FISH has been the most extensively studied technology in terms of the collaboration between pharmacy and medical intervention. Multiplex and broad-range molecular diagnostics are capable of lowering the result-time and increased sensitivity compared to growth-based blood culture systems.

There are thousands of pathogens known to cause disease in humans, and standard PCR assays have been developed to detect the most commonly occurring pathogens. Pyrosequencing and multitarget PCRs are two very useful strategies currently in development for clinical laboratories. Additionally, these new broad-based techniques have merit, based on their ability to identify organisms difficult to culture or newly emerging strains, as well as their capacity to track disease transmission.

Therefore, the market for microbial identification is expected to increase over the forecast period due to advancements in microbial identification which are enabling lower costs, lower result time and greater efficiency.

Scope of the Report

Microbial identification can be defined as "microbial characterization by a limited spectrum of tests pre-chosen and appropriate to the problem being studied."Following is the scope of the studied market report:

Key Market Trends

Instruments Lead the Product & Service Segment of Microbial Identification Market

There have been major advances in the identification techniques of clinically significant microorganisms. The spectrum of the identifiable organism has steadily increased over the years to become more inclusive of various microorganism strains. These include methods of faster identification of isolated organisms with mass spectrometry (MS) in clinical specimens and simpler.

The instruments available in the current market include AXIMA Microorganism Identification System, (manufactured by Shimadzu) and MicroSEQ Microbial Identification System (manufactured by Thermo Fischer Scientific), among others.

The above mentioned commercial instruments for microbial identification are based on techniques of mass spectrometry (MS), polymerase chain reaction (PCR) and time-of-flight mass spectrometry (TOF-MS). These advanced microbial identification systems are however not available uniformly across the globe, instead, their use is highly concentrated in North America and Europe region. Such factors give high opportunities for growth over the forecast period.

North America Holds the Largest Share in the Market

Being technologically advanced, North America has a good hold on the latest technologies that come into the market. Also, there is a good presence of big players in the North America region which indicates the availability of products related to microbial identification. However, there are some products of microbial identification which are yet to be approved in the United States which is acting as a barrier to the growth of the market over there.

Competitive Landscape

The market studied is moderately competitive and there are global as well as local players that are actively present in the market. In terms of major players, few companies are currently playing good and hold a healthy share in the market. Eg. Thermofisher Scientific, BioMerieux SA, Beckman Coulter, Inc., Shimadzu Corporation, and Becton, Dickinson and Company are the major players in the market along with the local and smaller companies that hold substantial share.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

TABLE OF CONTENTs

1. INTRODUCTION

  • 1.1. Study Deliverables
  • 1.2. Study Assumptions
  • 1.3. Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1. Market Overview
  • 4.2. Market Drivers
    • 4.2.1. Rising Incidence of Infectious Diseases
    • 4.2.2. Technological Advancements in Microbial Identification
    • 4.2.3. Increasing Food Safety Concerns
    • 4.2.4. Government Initiatives and Funding for Promoting Microbial Identification
  • 4.3. Market Restraints
    • 4.3.1. High Cost of Automated Microbial Identification Systems
  • 4.4. Porter's Five Force Analysis
    • 4.4.1. Threat of New Entrants
    • 4.4.2. Bargaining Power of Buyers/Consumers
    • 4.4.3. Bargaining Power of Suppliers
    • 4.4.4. Threat of Substitute Products
    • 4.4.5. Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1. By Products & Services
    • 5.1.1. Instruments
    • 5.1.2. Consumables
    • 5.1.3. Services
  • 5.2. By Method
    • 5.2.1. Phenotypic Methods
    • 5.2.2. Genotypic Methods
    • 5.2.3. Proteomics-Based Methods
  • 5.3. By Application
    • 5.3.1. Diagnostics
    • 5.3.2. Food & Beverage Testing
    • 5.3.3. Pharmaceuticals
    • 5.3.4. Cosmetics and Personal Care Products Testing
    • 5.3.5. Other Applications
  • 5.4. By End-User
    • 5.4.1. Hospitals, Clinics & Diagnostic Laboratories
    • 5.4.2. Food & Beverage Manufacturers
    • 5.4.3. Pharmaceutical Companies
    • 5.4.4. Other End Users
  • 5.5. Geography
    • 5.5.1. North America
      • 5.5.1.1. United States
      • 5.5.1.2. Canada
      • 5.5.1.3. Mexico
    • 5.5.2. Europe
      • 5.5.2.1. Germany
      • 5.5.2.2. United Kingdom
      • 5.5.2.3. France
      • 5.5.2.4. Italy
      • 5.5.2.5. Spain
      • 5.5.2.6. Rest of Europe
    • 5.5.3. Asia Pacific
      • 5.5.3.1. China
      • 5.5.3.2. Japan
      • 5.5.3.3. India
      • 5.5.3.4. Australia
      • 5.5.3.5. South Korea
      • 5.5.3.6. Rest of Asia-Pacific
    • 5.5.4. Middle East and Africa
      • 5.5.4.1. GCC
      • 5.5.4.2. South Africa
      • 5.5.4.3. Rest of Middle East and Africa
    • 5.5.5. South America
      • 5.5.5.1. Brazil
      • 5.5.5.2. Argentina
      • 5.5.5.3. Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1. Company Profiles
    • 6.1.1. Becton, Dickinson and Company
    • 6.1.2. Biolog, Inc.
    • 6.1.3. BioMerieux SA
    • 6.1.4. Bruker Corporation
    • 6.1.5. Charles River Laboratories International, Inc.
    • 6.1.6. Danaher Corporation
    • 6.1.7. Eurofins Scientific S.E.
    • 6.1.8. Merck Millipore (Merck KGaA)
    • 6.1.9. Shimadzu Corporation
    • 6.1.10. Thermo Fisher Scientific Inc.
    • 6.1.11. VWR Corporation

7. MARKET OPPORTUNITIES AND FUTURE TRENDS